NDC Package 0069-2377-10 Comirnaty

Covid-19 Vaccine,Mrna Injection, Suspension Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-2377-10
Package Description:
10 SYRINGE, GLASS in 1 CARTON / .418 mL in 1 SYRINGE, GLASS (0069-2377-01)
Product Code:
Proprietary Name:
Comirnaty
Non-Proprietary Name:
Covid-19 Vaccine, Mrna
Substance Name:
Raxtozinameran
Usage Information:
COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
11-Digit NDC Billing Format:
00069237710
NDC to RxNorm Crosswalk:
  • RxCUI: 2664837 - SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.3 ML Prefilled Syringe, 12y+
  • RxCUI: 2664837 - 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe
  • RxCUI: 2664841 - COMIRNATY 2023-2024 vaccine, 0.3 ML Prefilled Syringe, 12y+
  • RxCUI: 2664841 - 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Comirnaty 2023-2024]
  • RxCUI: 2664841 - 0.3 ML Comirnaty 2023-2024 0.1 MG/ML Prefilled Syringe
  • Product Type:
    Vaccine
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA125742
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-31-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-2377-10?

    The NDC Packaged Code 0069-2377-10 is assigned to a package of 10 syringe, glass in 1 carton / .418 ml in 1 syringe, glass (0069-2377-01) of Comirnaty, a vaccine label labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is injection, suspension and is administered via intramuscular form.

    Is NDC 0069-2377 included in the NDC Directory?

    Yes, Comirnaty with product code 0069-2377 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on October 31, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0069-2377-10?

    The 11-digit format is 00069237710. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-2377-105-4-200069-2377-10